Plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease

被引：0
|
作者：
Pilotto, A.
Ashton, N. J.
Lupini, A.
Battaglio, B.
Gipponi, S.
Cottini, E.
Grossi, I.
Salvi, A.
de Petro, G.
Pizzi, M.
Blennov, K.
Gonzalez, M.
Aarsland, D.
Zetterberg, H.
Padovani, A.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1243
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [41] Plasma extracellular vesicle pathognomonic proteins as the biomarkers of the progression of Parkinson's disease
    Hong, Chien-Tai
    Chung, Chen-Chih
    Hsieh, Yi-Chen
    Chan, Lung
    BIOSCIENCE TRENDS, 2025, 19 (01) : 116 - 124
  • [42] Differential cognitive features of Parkinson's disease dementia and Alzheimer's disease
    Saka, E.
    Elibol, B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S101 - S102
  • [43] Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease
    不详
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2012, 27 (01): : 77 - 77
  • [44] Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease
    Besser, Lilah M.
    Litvan, Irene
    Monsell, Sarah E.
    Mock, Charles
    Weintraub, Sandra
    Zhou, Xiao-Hua
    Kukull, Walter
    PARKINSONISM & RELATED DISORDERS, 2016, 27 : 54 - 60
  • [45] Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
    Xu, Yunqi
    Yan, Junqiang
    Zhou, Peng
    Li, Jiejie
    Gao, Huimin
    Xia, Ying
    Wang, Qing
    PROGRESS IN NEUROBIOLOGY, 2012, 97 (01) : 1 - 13
  • [46] Inflammatory biomarkers in Alzheimer's disease plasma
    Morgan, Angharad R.
    Touchard, Samuel
    Leckey, Claire
    O'Hagan, Caroline
    Nevado-Holgado, Alejo J.
    Barkhof, Frederik
    Bertram, Lars
    Blin, Olivier
    Bos, Isabelle
    Dobricic, Valerija
    Engelborghs, Sebastiaan
    Frisoni, Giovanni
    Froelich, Lutz
    Gabel, Silvey
    Johannsen, Peter
    Kettunen, Petronella
    Koszewska, Iwona
    Legido-Quigley, Cristina
    Lleo, Alberto
    Martinez-Lage, Pablo
    Mecocci, Patrizia
    Meersmans, Karen
    Luis Molinuevo, Jose
    Peyratout, Gwendoline
    Popp, Julius
    Richardson, Jill
    Sala, Isabel
    Scheltens, Philip
    Streffer, Johannes
    Soininen, Hikka
    Tainta-Cuezva, Mikel
    Teunissen, Charlotte
    Tsolaki, Magda
    Vandenberghe, Rik
    Visser, Pieter Jelle
    Vos, Stephanie
    Wahlund, Lars-Olof
    Wallin, Anders
    Westwood, Sarah
    Zetterberg, Henrik
    Lovestone, Simon
    Morgan, B. Paul
    Bullmore, Edward T.
    Bhatti, Junaid
    Chamberlain, Samuel J.
    Correia, Marta M.
    Crofts, Anna L.
    Dickinson, Amber
    Foster, Andrew C.
    Kitzbichler, Manfred G.
    ALZHEIMERS & DEMENTIA, 2019, 15 (06) : 776 - 787
  • [47] MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression
    Schilling, Marcel
    Lill, Christina M.
    MOVEMENT DISORDERS, 2021, 36 (08) : 1793 - 1793
  • [48] Cerebrospinal fluid biomarkers in Alzheimer's disease, Parkinson's disease and atypical parkinsonism
    Stojmenovic, G. Mandic
    Markovic, I.
    Stojkovic, T.
    Despotovic, I.
    Lukic, M. Jecmenica
    Stefanova, E.
    Kostic, V.
    MOVEMENT DISORDERS, 2012, 27 : S386 - S386
  • [49] Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
    Irwin, David J.
    Fedler, Janel
    Coffey, Christopher S.
    Caspell-Garcia, Chelsea
    Kang, Ju Hee
    Simuni, Tanya
    Foroud, Tatiana
    Toga, Arthur W.
    Tanner, Caroline M.
    Kieburtz, Karl
    Chahine, Lana M.
    Reimer, Alyssa
    Hutten, Samantha
    Weintraub, Daniel
    Mollenhauer, Brit
    Galasko, Douglas R.
    Siderowf, Andrew
    Marek, Kenneth
    Trojanowski, John Q.
    Shaw, Leslie M.
    ANNALS OF NEUROLOGY, 2020, 88 (03) : 574 - 587
  • [50] The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease
    Pawlik, Patrycja
    Blochowiak, Katarzyna
    DIAGNOSTICS, 2021, 11 (02)
12345